Key statistics dashboard for Protagenic Therapeutics, Inc. (PTIX). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California.
Stock Data
| Price | $0.84 |
| Market Cap | $2M |
| Exchange | OTC |
| Country | US |
Valuation Multiples
| P/E Ratio | 0.28 |
| Price / Book | 0.88 |
| P/S | 0.00 |
| P/FCF | -0.59 |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 0.00% |
| EBIT Margin | 0.00% |
| EBITDA Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
Financial Health
| Current Ratio | 0.66 |
| Quick Ratio | 0.66 |
| Cash Ratio | 0.53 |
| Debt / Equity | 0.00 |
| Debt / Assets | 0.00% |
| Interest Coverage | -3.13 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -17.34 |
Per-Share Data
| Revenue per share | 0.00 |
| Book Value per share | 0.56 |
| Cash per share | 0.31 |
| FCF per share | -1.43 |
| Tangible Book Value per share | -0.59 |
| Dividend per share | 0.00 |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 1 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 1 |
| Avg rating (1-5) | 1.00 |
Related companies: ARTL · CARM · GTBP · INDP · LIPO · PBM · REVB
Explore sector: Healthcare · Biotechnology
More sections of PTIX: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks